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Abstract  
The use of graphene nanomaterials (GNMs) for biomedical applications targeted to the central 
nervous system is exponentially increasing, although precise information on their effects on 
brain cells is lacking. In this work, we addressed the molecular changes induced in cortical 
astrocytes by few-layer graphene (FLG) and graphene oxide (GO) flakes. Our results show 
that exposure to FLG/GO does not affect cell viability or proliferation. However, proteomic 
and lipidomic analyses unveiled alterations in several cellular processes, including 
intracellular Ca2+ ([Ca2+]i) homeostasis and cholesterol metabolism, which were particularly 
intense in cells exposed to GO. Indeed, GO exposure impaired spontaneous and evoked 
astrocyte [Ca2+]i signals and induced a marked increase in membrane cholesterol levels. 
Importantly, cholesterol depletion fully rescued [Ca2+]i dynamics in GO-treated cells, 
indicating a causal relationship between these GO-mediated effects. Our results indicate that 
exposure to GNMs alters intracellular signaling in astrocytes and may impact on astrocyte-
neuron interactions. 
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1. Introduction 
 
Because of their unique physical and chemical properties, graphene nanomaterials (GNMs) 
are currently exploited for a range of applications in tissue engineering, regenerative medicine 
and drug/gene delivery to the central nervous system (CNS).[1,2] The implementation of 
strategies that make use of GNMs for neurological applications, however, requires a detailed 
knowledge of the impact of such materials on the biology of the various CNS cell populations. 
The impact of GNMs on the morphological and functional properties of primary neurons has 
been extensively described.[3-6] Conversely, a detailed description of the biological 
interactions between GNMs and glial cells has not been fully addressed yet. 
Amongst the various glial subtypes populating the CNS, astrocytes represent 20-40 % of 
cells.[7] Astrocytes actively contribute to the activity of neural circuits by controlling the 
dynamics of the perineuronal milieu through their capacity to maintain the extracellular ion 
and neurotransmitter homeostasis.[8,9] Moreover, astrocytes are involved in the structural 
remodeling of neural networks by directing synapse formation and pruning, regulating brain 
metabolism and participating in the neurovascular coupling.[10,11] Many of these functions are 
mediated by dynamic variations in intracellular calcium levels ([Ca2+]i), which follow the 
paracrine activation of metabotropic receptors by signaling molecules released from cells of 
neuronal, glial and vascular origin.[12] Of note, alterations of astroglial [Ca2+]i dynamics are 
observed under several central nervous system diseases; however, whether this dysregulation 
plays a pathogenic role or reflects reparative processes following brain damage is still 
unclear.[10,13-17] These diverse roles can be fulfilled because of the ability of astrocytes to 
respond to a large variety of environmental cues through alterations of their molecular and 
functional properties.[18-20] Whether astroglial plasticity can be influenced by exposure to 
various nanomaterials remains to be established. 
A limited number of studies have described the specific effects induced by G-related materials 
(GRMs) on astrocytes. Single-walled carbon nanotubes (SWCNTs) administered as 
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dispersions, strongly affected the viability of chicken-derived glial cell cultures. On the 
contrary, functionalized water-soluble SWCNTs induced stellation of mouse cortical 
astrocytes and increased GFAP expression, in the absence of sizeable effects on cell 
viability.[21] PEG-SWCNT films had differential effects on astrocytes, with thinner films 
inducing stellation, and thicker films promoting de-differentiation with cell enlargement, 
reduced GFAP expression and increased proliferation.[22,23] Graphene oxide (GO) did not 
affect astrocyte viability in vitro.[5,24] We have recently shown that GO impacts on astrocyte 
homeostatic functions by affecting their ability to buffer extracellular K+ and glutamate, with 
repercussions on the excitability of co-cultured neurons.[24] Although, the cellular and 
molecular mechanisms underlying the graphene-mediated changes in the astroglial phenotype 
remain to be identified, injection of reduced GO flakes in the rodent hippocampus did not 
induce reactive astrogliosis, indicating that GNMs are well tolerated also in vivo.[25] 
In this work, we studied the effects of long-term exposure of primary cortical astrocytes to 
few-layer graphene (FLG) and GO on their proteomic and lipidomic profiles. The analysis 
identified profound alterations in the intracellular protein networks that control Ca2+ signaling, 
accompanied by a marked increase in cell cholesterol that was causally related to Ca2+ 
dysregulation. The effects of GNMs on astrocyte signaling and activation may impact on the 
functional astrocyte-neuron interactions. 
 
2. Results 
2.1 Production and characterization of FLG / GO flakes 
The GRMs used in the present study were FLG and GO flakes. FLG was prepared by 
exfoliation of graphite through interaction with melamine by ball-milling treatment.[26] After 
exfoliation, melamine was removed to obtain stable dispersions of FLG in H2O. GO, provided 
by the Grupo Antolin Ingeniería (Burgos, Spain), was obtained by oxidation of carbon fibers 
(GANF Helical-Ribbon Carbon Nanofibres, GANF®). Initial GO suspensions were washed 
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with H2O to remove the presence of acids and were fully characterized. Transmission electron 
microscopy (TEM) analysis revealed a similar lateral size distribution of FLG and GO, 
showing high polydispersity of the solutions ranging from 100 to 1,500 nm (Figure 1a-c). In 
both FLG and GO, Raman spectroscopy displayed the two main features of G-based 
materials: the so-called D and G peaks corresponding to disordered carbon and to the sp2 
tangential mode, respectively.[27] The D band appeared at 1347 cm-1 and the G peak arose at 
~1,576 cm-1. The average spectrum of FLG showed an I(D)/I(G) ratio of about 0.26, 
confirming a low level of defects located at the edges of the micrometer flakes (Figure 1d). In 
contrast, the GO average spectrum displayed broad D and G bands with an I(D)/I(G) ratio of 
about 0.88. A 2D band (~2,700 cm-1) was observed in the FLG structure, while the GO 
spectrum instead displayed a bump. Accordingly, elemental analysis gave very different 
results between the two GNMs, as displayed in Figure 1e, with an amount of oxygen around 
5% (w/w) in FLG and 49% in GO. Finally, thermo-gravimetric analysis (TGA) was used to 
quantify the degree of functionalization of FLG and GO (Figure 1f). In agreement with 
Raman and elemental analyses, the weight loss observed in FLG at 600 ºC was only 8.5%, 
confirming the low quantity of oxygen groups generated by the exfoliation process in 
comparison to GO, whose TGA displayed a weight loss of 49.2%. 
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Figure 1. Characterization of FLG and GO. (a-c) Representative TEM images of FLG (a) 
and GO (b) used throughout the study and their respective lateral size distribution (c; n≥107). 
Scale bars, 500 nm. (d) Average Raman spectra (n≥30) of FLG and GO. (e,f) Elemental (e) 
and thermo-gravimetric (f) analysis of FLG and GO samples. 
 
2.2 FLG and GO do not affect astrocyte viability and cell cycle and proliferation 
Primary astrocytes were exposed to FLG/GO (1 and 10 µg/ml) or to the corresponding 
vehicle solution (0.046 ppm melamine/H2O for FLG or H2O for GO) for up to 7 days, and 
cell viability was investigated at various time points by flow cytometry by using propidium 
iodide (PI) and AlexaFluor488-conjugated Annexin V to detect early and late apoptotic cells, 
respectively. As a positive control, cells were treated with the strong inducer of apoptosis 
staurosporine (POS; 1 µM) (Figure 2a-c). Cell viability was also assessed after a 2-day 
exposure of confluent cultures of mature astrocytes to FLG/GO (Figure 2d). Exposure to 
either FLG or GO did not induce cell death at any of the tested concentrations and exposure 
times. Since no dose-dependent effects were observed on cell viability, all subsequent 
experiments were performed using the highest GNM concentration (10 µg/ml). 
 We subsequently evaluated cell division and cell cycle upon exposure to FLG/GO. 
The cell number in untreated and FLG/GO-treated samples showed comparable changes over 
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time, suggesting a negligible effect of the material on astrocyte division (Figure 2e). In 
accordance with these data, flow-cytometry analysis showed that FLG/GO treatment did not 
affect the percentage of cells in the various cell cycle phases (Figure 2f,g). 
We next evaluated whether exposure to GNMs led to astrogliosis (Figure 2h-k). To 
this end, astrocyte cultures were immunostained with antibodies to the intermediate filament 
glial fibrillary acidic protein (GFAP; Figure 2h), a classical marker of reactive gliosis.[28,29] 
The levels of GFAP were not altered by the exposure to FLG/GO, as shown from both 
immunostaining (Figure 2h,i) and western blot (Figure 2j,k) analysis. 
These results indicate that exposure to FLG and GO does not affect astrocyte proliferation, 
survival and reactivity. 
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Figure 2. Exposure to FLG/GO does not alter astrocyte viability, cell cycle and reactivity. 
(a-c). Primary rat astrocytes were exposed to either FLG or GO (1 and 10 µg/ml) or to an 
equivalent volume of the respective vehicle (Ctrl: 0.046 ppm melamine/H2O for FLG, H2O 
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for GO) for 24 h (a), 72 h (b) and 7 d (c). Staurosporine (POS; 1 µM) was used as a positive 
control for apoptosis. Cell death was evaluated by flow cytometry analysis of Annexin-V 
(AxV; early apoptotic events) and propidium iodide (PI; late apoptosis) staining. The 
percentages of AxV- and PI-positive cells with respect to the total number of cells were 
calculated for each experimental group. (d) The same experimental procedure was carried out 
for primary glial cultures at confluence, exposed for 48 h to either FLG or GO. No changes in 
cell death were observed under all the experimental conditions. p>0.05, Student’s t-test; 
45,000 cells from 3 replicates per experimental condition from n = 3 independent preparations. 
(e) Growth curve of primary astrocytes exposed to FLG and GO for 24 h, 72 h and 7 d. No 
differences were found compared to vehicle-treated (Ctrl) samples (3 replicates per 
experimental condition, from n = 3 independent preparations); p>0.05, repeated measures 
ANOVA. (f,g) Primary astrocytes were exposed to FLG/GO for 72 h (f) and 7 d (g). Samples 
were processed by flow cytometry and analyzed for PI fluorescence intensity. No differences 
were observed in cell cycle phases across all experimental conditions. p>0.05, one-way 
ANOVA; 45,000 cells from 3 replicates per experimental condition, from n = 3 independent 
preparations. (h-k) GFAP expression upon exposure to FLG/GO. Primary astrocytes were 
exposed to 10 µg/ml of FLG/GO for 72 h and GFAP expression was quantified by 
immunofluorescence (h,i) and immunoblotting (j,k). Representative images (h) and 
quantification of fluorescence intensity (i) of astrocytes stained for GFAP (green) and 
Hoechst (blue) for nuclei visualization. Scale bar, 30 µm. p>0.05, one-way ANOVA; 60 cells 
from n = 3 independent cell preparations. Representative Western blots (j) and quantification 
of the GFAP immunoreactivity (k) in astrocytes upon exposure to either FLG or GO. Gapdh 
was used as loading control. p>0.05, one-way ANOVA; n = 3 independent preparations. Data 
are expressed as means ± sem in all panels. 
 
2.3 FLG / GO exposure differentially affects the proteomic profile of primary astrocytes 
To get a more comprehensive understanding of the intracellular pathways affected by 
exposure to GNMs, proteomics (Figure 3) and lipidomics (Figure 4) screens were carried out 
on primary astrocytes treated with either FLG or GO for 72 h. We performed untargeted LC-
MS/MS-based proteomics by labeling the protein content of astrocytes exposed to GO, FLG 
or their corresponding vehicles with TMT isobaric tags.[30] Our analysis revealed 255 and 80 
proteins significantly altered following GO and FLG treatment, respectively (p≤0.05). The 
corresponding Venn diagram analysis showed only 21 proteins shared by the two groups 
(Figure 3a). Gene ontology analysis confirmed the upregulation of key cellular processes. 
Pathways related to cytoskeletal organization and lipid binding were altered in both FLG and 
GO-treated samples, although the altered proteins within each category were often different 
between the two groups (Figure 3b,c), in agreement with the Venn diagram. Interestingly, 
calcium binding and glutamate receptor-binding proteins were specifically altered in GO-
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treated cells (Figure 3c). Changes in the expression of selected Ca2+ binding proteins were 
also validated by RT-PCR (Figure S1). 
 
 
Figure 3. Proteomic profile of primary astrocytes exposed to FLG/GO. (a) Venn diagram 
showing the number of unique proteins undergoing significant expression changes upon 
FLG/GO exposure. Only 21 proteins are in common between the two groups. (b,c) Clustered 
heat-maps of pathway enrichment analysis in primary astrocytes exposed to FLG (b) or GO 
(c). n = 5 replicates from 2 animals. P values were calculated using the Benjamini-corrected 
modified Fisher’s exact test and are reported in the Supplementary Excel Files. 
 
2.4 FLG / GO exposure differentially affects the lipidomic profile of primary astrocytes 
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Untargeted lipidomics revealed substantial changes in the lipid composition of astrocytes 
treated with FLG/GO (Figure 4a,b). Relevant changes in 46 lipids were found, belonging to 
several classes, such as phosphatidylethanolamines (PE), phosphatidylinositols (PI), 
phosphatidylserines (PS), phosphatidylcholines (PC), diacylglycols (DG), triacylglycerols 
(TG), hexosyl-ceramides (Hex-Cer) and sterols. Amongst these lipid classes, phospholipid, 
cholesterol and triglyceride levels were significantly altered following exposure of astrocytes 
to either FLG or GO (Figure 4c,d; Supplementary Excel Files). PCs were upregulated by 
GO and downregulated by FLG, while an opposite modulation was observed for TGs (Figure 
4c). Interestingly, both cholesteryl esters (such as CE 18:1) and free cholesterol, that are 
produced by astrocytes in the brain,31 were markedly upregulated by GO (Figure 4d). 
Cholesterol plays a crucial role in astrocyte physiology, as it rapidly re-distributes in the 
cell membrane in response to a variety of stimuli,[32-34] and is linked to lipid raft assembly and 
Ca2+ signaling.[35] To get more insights into the mechanisms underlying the variations of 
cholesterol levels induced by GO, we stained primary astrocytes with the cholesterol-specific 
fluorescent marker filipin. In agreement with the lipidomics results, GO-exposed astrocytes 
displayed strongly increased cholesterol levels with respect to vehicle-treated cells, while 
FLG induced only a small increase in filipin staining (Figure 4e). 
Highly concentrated cholesterol in the plasma membrane is a feature of lipid rafts, membrane 
microdomains characterized by clusters of lipids and a variety of signaling and scaffolding 
proteins, including ion channels.[36] We evaluated whether FLG/GO exposure affected raft 
distribution and organization by live labeling GNM-treated and control astrocytes with the 
fluorescently labeled cholera toxin B-subunit (Vybrant) that recognizes the GM1 ganglioside, 
a specific marker of membrane rafts (Figure 4f,g). Exposure to GO selectively induced an 
increase in total Vybrant fluorescence (Figure 4g, top left), average size of the lipid rafts 
(Figure 4g, top right) and raft membrane coverage (Figure 4g, bottom left). Moreover, the 
size distribution of GO-induced lipid rafts was shifted toward higher values (>10 µm2), 
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indicating that GO-treated cells displayed a higher number of lipid rafts of larger size (Figure 
4g, bottom right). 
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Figure 4. Lipidomic profiles of primary astrocytes exposed to FLG/GO. (a,b) Score plots 
from principal component analysis of untargeted lipidomics data. Dots representing individual 
astrocyte samples clusterize into two distinct groups (treated/control) for both GO (a) and 
FLG (b) exposure. (c) Changes induced in phosphatidylcholine (left) and triacylglycerol 
(right) content following exposure to GO or FLG. (d) Changes in oleoyl-cholesterol ester and 
free cholesterol content in FLG/GO treated astrocytes expressed in percentage of the 
respective vehicle-treated sample. * p<0.05; ** p<0.01; Student’s t-test, n=5 replicates from 2 
animals. (e) Representative images (left) and quantification of fluorescence intensity (right) of 
filipin-stained astrocytes after treatment with either vehicle or FLG/GO for 72 h. Scale bar, 20 
µm. 30 cells from n = 3 independent cell preparations. (f,g) Representative images (f) and 
quantification of the fluorescence intensity of Vybrant-positive rafts (g) after treatment with 
either vehicle or FLG/GO for 72 h. In GO-treated cells, lipid rafts displayed increased mean 
fluorescence intensity, larger size and larger membrane coverage. n=20 cells, from 2 
independent preparations. In (e-g): * p<0.05; ** p<0.01; *** p<0.001, one-way 
ANOVA/Bonferroni’s multiple comparison tests. Data are expressed as means ± sem in all 
panels. 
 
2.5 Exposure to GO inhibits intracellular Ca2+ signaling 
As described above, treatment with GO specifically perturbed the cellular pathways involved 
in [Ca2+]i homeostasis. To gain more insights into the functional consequences of these 
changes, we exposed primary astrocytes to FLG/GO for 72 h and analyzed [Ca2+]i dynamics 
by live imaging of single-cells loaded with the Ca2+-sensitive dye FURA2-AM (Figure 5). 
FLG- and GO-treated cultures displayed a reduction in the percentage of cells showing 
spontaneous [Ca2+]i transients compared to vehicle-treated cultures, which was accompanied 
by a reduction in the frequency of spontaneous [Ca2+]i oscillations and significantly lower 
basal [Ca2+]i levels (Figure 5a), which reached statistical significance only in GO-treated 
astrocytes. GO-treated cells also showed significantly impaired ATP-evoked [Ca2+]i 
elevations (Figure 5b). 
 To unravel the mechanisms underlying the observed effects, we asked whether GO 
alters the release of Ca2+ from intracellular stores and/or the influx of Ca2+ through the plasma 
membrane.[37] To address this issue, we exposed GO-treated astrocytes to thapsigargin in 
Ca2+-free extracellular saline to deplete intracellular Ca2+ stores (Figure 5c).[38] Interestingly, 
GO-treated astrocytes showed a significantly decreased response to thapsigargin, indicating 
an impairment of the intracellular Ca2+ storage/Ca2+ release mechanisms. When the 
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extracellular Ca2+ concentration was returned to 2 mM to promote Ca2+ entry through 
membrane store-operated Ca2+ channels (SOC), GO-treated astrocytes displayed a 
significantly lower increase in [Ca2+]i than that evoked in vehicle-treated astrocytes (Figure 
5c). These results corroborate those of the proteomic screening, showing that exposure of 
primary astrocytes to GO causes a complex dysregulation of [Ca2+]i signaling that affects the 
various mechanisms involved in [Ca2+]i homeostasis. 
 
 
Figure 5. Alteration of [Ca2+]i in primary astrocytes treated with FLG/GO. (a) 
Representative spontaneous [Ca2+]i oscillations recorded in astrocytes treated with FLG/GO 
for 72 h (top left); percentage of spontaneously active cells (top right), frequency of [Ca2+]i 
oscillations under basal conditions (bottom left) and basal [Ca2+]i levels (bottom right) are 
shown. *p<0.05, one-way ANOVA/Bonferroni’s multiple comparison tests; n = 10 coverslips 
per experimental condition from 4 independent cell preparations. (b) Top: Representative 
[Ca2+]i responses evoked by ATP (10 µM) in astrocytes treated for 72 h with FLG/GO and 
quantification of DF/F0values (bottom) in response to ATP. *p<0.05, **p<0.01 one-way 
ANOVA/Bonferroni’s multiple comparison tests; n = 10 coverslips per experimental 
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condition from 3 independent preparations (Ctrl, 21; FLG, 25; GO, 21 cells). (c) Left: 
Representative images of FURA2-AM-loaded astrocytes exposed to vehicle (Ctrl) or GO 
under basal conditions and upon addition of thapsigargin (TS; 1 µM), in the absence or 
presence of 2 mM extracellular Ca2+, as indicated. Scale bar, 10 µm. Representative traces of 
[Ca2+]i transient peaks (middle) and changes in DF/F0 values (right) triggered by TS in Ca2+-
free external medium (0 Ca2+ ext) and after replacement of the external solution with a Ca2+-
containing saline (2 mM Ca2+ ext). *p<0.05, Mann Whitney U-test (n = 10 cells per 
experimental condition from 3 independent preparations). Data are expressed as means ± sem 
in all panels. 
 
2.6 Cholesterol depletion rescues [Ca2+]i dynamics in GO-treated astrocytes 
A number of studies have suggested that cholesterol plays a regulatory role in [Ca2+]i 
homeostasis in various cellular contexts.[39-41] Since cholesterol levels markedly increased in 
GO-treated cells, we next asked whether the alterations of [Ca2+]i dynamics induced by GO 
could be causally linked to the increase in cholesterol content. To address this question, we 
incubated vehicle- and GO-treated astrocytes with the cholesterol-depleting agent methyl-β-
cyclodextrin (MβCD, 7.5 mM) for 30 min and analyzed [Ca2+]i dynamics (Figure 6). 
Analysis of filipin staining showed that the treatment with MβCD indeed decreased 
endogenous cholesterol from control astrocytes. Remarkably, in astrocytes exposed to GO, 
the administration of MβCD decreased filipin staining to levels similar to those of vehicle-
treated cells (Figure 6a). [Ca2+]i dynamics upon thapsigargin treatment were not significantly 
affected by MβCD exposure in vehicle-treated astrocytes (Figure 6b, left and c). By contrast, 
in GO-treated astrocytes the MβCD incubation rescued [Ca2+]i signals, which returned to 
levels comparable to those of vehicle-treated cells (Figure 6b, right and c). Altogether, these 
data demonstrate the existence of a functional correlation between the increase in cholesterol 
and the alteration of [Ca2+]i dynamics induced by GO. 
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Figure 6. Cholesterol depletion rescues GO-induced alterations of [Ca2+]i  dynamics. (a) 
Primary astrocytes that had been exposed to either vehicle or GO for 72 h were incubated in 
the presence or absence of MβCD for 30 min. Representative images (left) and quantification 
of filipin staining (right) used to visualize the effects of the treatments on cholesterol levels. 
Scale bar, 50 µm. **p<0.01, two-way ANOVA/Bonferroni’s multiple comparison tests; n = 
8-10 fields per experimental condition from 2 independent preparations. (b,c) Representative 
traces of [Ca2+]i signals (b) and quantification of ΔF/F0 values (c) in primary astrocytes that 
had been exposed to vehicle (Ctrl, left) or GO (right) and subsequently incubated in the 
absence or presence of MβCD for 30 min. Astrocytes were challenged with TS (1 µM) in the 
absence of extracellular Ca2+ (0 Ca2+ ext), followed by replacement of the external solution 
with a Ca2+-containing saline (2 mM Ca2+ ext). *p<0.05, ***p<0.001; two-way 
ANOVA/Bonferroni’s multiple comparison tests (n ≥ 12 cells per experimental condition 
from 2 independent preparations). Data are expressed as means ± sem in all panels. 
 
3. Conclusion and Discussion 
It is well known that astrocytes in vivo respond to pathological insults through complex 
molecular and functional changes that modify their homeostatic properties and alter the 
structural and functional integrity of the neuronal tissue.[42] These dynamic changes define 
astrocyte reactivity and can be detrimental or beneficial according to the pathological settings. 
The upregulation of GFAP expression has been considered a marker of astrocyte reactivity 
and a landmark of various pathological conditions such as CNS insults, ischemia and several 
neurodegenerative diseases.[43] Although cultured astrocytes avidly uptake GNMs through the 
endo-lysosomal pathway,[24] here we show that exposure to GNMs does not affect astrocyte 
viability and does not cause any significant alteration in cell cycle progression. In addition, 
the expression of GFAP is unaltered, indicating that, at least in vitro, exposure of cortical 
astrocytes to GNMs does not trigger reactive astrogliosis. 
 The physico-chemical properties of GNMs are dictated by their size, shape and 
chemistry, which in turn determine the biological effects they cause upon interaction with 
living organisms.[44] Our study shows that exposure to GNMs profoundly affects the proteome 
of cultured astrocytes. While over 300 proteins showed appreciable changes upon GO 
treatment, only 100 were altered by FLG, and remarkably, only 21 proteins were common to 
the two materials. This supports the notion that the distinct features of FGL and GO flakes 
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strongly influence their interaction with cultured cells, triggering the activation of distinct, 
almost non-overlapping pathways. The common processes affected by both FLG and GO 
include cytoskeleton remodeling and lipid binding proteins. The observed alteration of 
cytoskeletal proteins is in line with the marked shape change displayed by GNM-treated 
astrocytes, which acquire a highly elongated morphology reminiscent of activated cells.[24] 
The impact of GNMs on lipid binding proteins is of interest, as it correlates with the wide 
array of lipid species that are up- or downregulated in GNM-exposed cells, particularly 
cholesterol. 
 The lipidomic screen revealed that phospholipid, cholesterol and triglyceride 
metabolism is significantly altered following exposure of astrocytes to GO and FLG. PCs, the 
most abundant structural phospholipids playing a crucial role in the modulation of membrane 
fluidity,[45] are up-regulated by GO and down-regulated by FLG, while TGs, the main storage 
form of lipid precursors,[45] show an opposite modulation. Interestingly, cholesteryl esters and 
free cholesterol, fundamental lipids produced by astrocytes in the brain,[31,46] are markedly 
upregulated by GO. Brain cholesterol is mainly synthetized in situ, since dietary supply is 
fenced off by the blood-brain barrier. In the adult brain, most of cholesterol is produced by 
astrocytes in support to the metabolic needs of neurons.[31,46] Thus, the observed increase in 
cholesterol, in addition to cell-autonomous effects on astrocytes, may impact on the metabolic 
and electrical activity of co-cultured neurons. Interestingly, and in line with our findings, 
increased membrane cholesterol levels have been recently reported in primary neurons and 
cell lines grown onto to graphene substrates. Remarkably, cholesterol was the principal 
mediator of the cellular and physiological alterations induced by graphene on the overlying 
cell cultures.[47] 
 Amongst the pathways specifically altered by GO, a prominent role is played by Ca2+-
binding proteins. Indeed, analysis of single cell [Ca2+]i dynamics shows that GO, but not FLG, 
causes significant alterations of both spontaneous and evoked [Ca2+]i signals. Moreover, both 
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Ca2+ release from intracellular stores and Ca2+ entry through the plasma membrane are down-
regulated by GO exposure. It is well known that [Ca2+]i signaling is instrumental for astrocyte 
homeostatic functions and astrocyte-neuron communication.[48] Notably, alterations of 
astrocyte [Ca2+]i dynamics have been associated with a number of CNS dysfunctions.[49] A 
decrease in ATP- and neurotransmitter-evoked [Ca2+]i signaling has been reported in 
astrocytes during aging.[50,51] By contrast, pathological elevation of both spontaneous and 
evoked [Ca2+]i responses in astrocytes have been described in a mouse model of Alzheimer’s 
disease.[52] In focal ischemia, the spreading of cell death from the ischemic core to adjacent 
areas is mediated by [Ca2+]i waves triggered by the massive release of ATP and activation of 
P2Y purinergic receptors.[15,53] More recent data have shown that enhanced astrocytic [Ca2+]i 
responses actively contribute to some forms of epilepsy.[54,55] Based on this evidence, the 
demonstration that GO depresses [Ca2+]i dynamics in primary astrocytes corroborates the 
view that this material could affect CNS functions in vivo also through changes in astrocyte-
astrocyte and astrocyte-neuron signaling. 
The efficacy of Ca2+ signaling in astrocytes relies on the efficient replenishment of the 
ER store through store-operated Ca2+ entry (SOCE). This process is mediated by the dynamic 
interactions between the ER protein STIM and the plasma membrane protein ORAI that 
predominantly occur at membrane rafts.[56-58] Cholesterol-rich membrane rafts are essential 
for the efficient propagation of Ca2+ transients, as they assemble the required repertoire of 
Ca2+ channels and receptors to sense external stimuli and translate them into the activation of 
appropriate intracellular signaling cascades.[59] Recently, a cholesterol-binding domain was 
identified in STIM1. The binding of STIM1 to cholesterol prevents the interaction with ORAI, 
and consequently inhibits Ca2+ influx from the extracellular environment into the cell.[60] In 
line with this evidence, our results indicate that cholesterol depletion is sufficient to rescue 
[Ca2+]i dynamics in GO-treated cells, while the expression levels of the various SOCE 
components were not directly affected by GNM exposure (not shown). Thus, by increasing 
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the total amount of membrane cholesterol, GO may inhibit the proper functioning of SOCE 
and consequently impair the generation and propagation of intracellular [Ca2+]i waves. 
Collectively, our current and previously published results[6,24] support the view that GO is an 
exploitable material for biomedical applications in neuromedicine, since it is not harmful to 
neurons and astrocytes and regulates important astrocyte homeostatic functions. However, 
since GO affects the balance between excitatory and inhibitory signaling in neuronal 
networks[6] and modulates [Ca2+]i dynamics in primary astrocytes through changes in 
cholesterol levels, its applicability as functional substrate for prosthetic devices remains to be 
unequivocally determined. In this context, future studies will address whether the GO-induced 
effects described here are relevant for the proper functionality of the astrocyte syncytium and 
neuron-astrocyte communication in vivo. 
 
4. Experimental Section  
Synthesis and characterization of pristine graphene and graphene oxide 
Few-layer graphene (FLG) flakes were prepared by exfoliation of graphite through interaction 
with melamine by ball-milling treatment.[61] Elemental analysis revealed that FLG contained 
0.46% (w/w) melamine, corresponding to 0.046 ppm for a 10 µg/ml FLG suspension. 
Graphene oxide (GO) was provided by Grupo Antolin Ingeniería (Burgos, Spain) by 
oxidation of carbon fibers (GANF Helical-Ribbon Carbon Nanofibres, GANF®) and sodium 
nitrate in sulfuric acid at 0 °C. For a detailed description of FLG and GO synthesis and 
physical-chemical characterization, please refer to (Leon et al., 2016)[26] and (Bramini et al., 
2016)[6]. 
 
Preparation of primary astrocytes 
All experiments were carried out in accordance with the guidelines established by the 
European Community Council (Directive 2010/63/EU of 22 September 2010) and were 
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approved by the Italian Ministry of Health (Authorization #306/2016-PR of March 24, 2016). 
Primary cultures were prepared from wild-type Sprague-Dawley rats (Charles River, Calco, 
Italy). All efforts were made to minimize suffering and to reduce the number of animals used. 
Rats were sacrificed by CO2 inhalation, and 18-day embryos (E18) were removed 
immediately by cesarean section. Briefly, enzymatically dissociated astrocytes were plated on 
poly-D-lysine-coated (0.01 mg/ml) cell culture flasks and maintained in a humidified 
incubator with 5% CO2 for 2 weeks. At confluence astrocytes were enzymatically detached 
using trypsin–EDTA and plated on glass coverslips (Thermo-Fischer Scientific, Waltham, 
MA) at a density of 20,000-40,000 cells/ml, depending on the experiment. Cultures were 
incubated at 37 °C, 5% CO2, 90% humidity in medium consisting of DMEM (Gibco/Thermo-
Fischer Scientific) supplemented to reach the final concentration of 5% glutamine, 5% 
penicillin/streptomycin and 10% Fetal Bovine Serum (FBS; Gibco/Thermo-Fischer 
Scientific). For experiments involving G treatments, cultures were incubated at 1 day in vitro 
(DIV) in a medium containing either 1 or 10 µg/ml of either FLG or GO. Controls were 
subjected to the same medium change with the addition of equivalent volumes of the 
respective vehicle (0.046 ppm melamine/H2O for FLG, H2O for GO). Cultures were used at 
DIV 2, 4 and 8 (i.e., after 1, 3 and 7 days of FLG/GO incubation, respectively). All chemicals 
were purchased from Life Technologies/Thermo-Fischer Scientific unless stated otherwise. 
 
Cell viability assay and cell cycle analysis 
Primary astrocytes were exposed to FLG or GO (1 and 10 µg/ml), or to equivalent volumes of 
the respective vehicle (0.046 ppm melamine/H2O for FLG or H2O for GO) for 24 h, 72 h and 
7 d. The medium was collected in flow-tubes and cells were detached by trypsin EDTA 
0.25% (Gibco/Thermo-Fischer Scientific) and re-suspended in 500 µl phosphate-buffered 
saline (PBS) in the same flow-tubes of the medium. Cells were stained with propidium iodide 
(PI, 1 µM) for late apoptosis quantification, and AlexaFluor-488 conjugated Annexin V 
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(Molecular Probes, 5 µM) for early apoptosis quantification. Cells were incubated at room 
temperature (RT) for 15 min in the dark. Cells incubated for 8 h with staurosporin (POS; 1 
µM; Sigma Aldrich) were used as positive control for apoptotic cell death. Cell death assays 
were performed by flow-cytometry analysis using a BD Facs Aria II Cell Sorter (Becton 
Dickinson, NJ, USA). 
For cell counting experiments, primary astrocytes were exposed to 10 µg/ml FLG/GO 
for 24 h, 72 h and 7 d. Cells were then collected, stained with trypan blue solution (Sigma-
Aldrich), and counted using a Neubauer chamber (Sigma-Aldrich). 
For cell cycle analysis, primary astrocytes were trypsinized and collected in flow-
tubes. Cells were fixed in 70% EtOH for 40 min at -20 °C, centrifuged and the pellet was 
finally resuspended in 500 µl of 0.2 mg/ml RNase A, 0.05% Triton X-100 and 60 µg/ml PI for 
1 h at RT. After the incubation, samples were centrifuged and cell pellet re-suspended in 500 
µl PBS for flow analysis. When analyzing samples, the PI fluorescent signal was collected in 
a linear scale using a FACS Aria II Cell Sorter (Becton Dickinson, NJ, USA). Samples were 
analyzed at a low flow rate under 400 events/s. 
 
Immunofluorescence staining 
Primary astrocytes were fixed in PBS /4% paraformaldehyde (PFA) for 20 min at RT. Cells 
were permeabilized with 1% Triton X-100 for 5 min, blocked with 2% fetal bovine serum 
(FBS) in PBS/0.05% Tween-80 for 30 min at RT and incubated with primary antibodies in the 
same buffer for 45 min. The primary antibody used was mouse monoclonal anti-glial 
fibrillary acidic protein (GFAP, #G3893, Sigma-Aldrich). After the incubation with primary 
antibodies and several PBS washes, neurons were incubated for 45 min with the secondary 
antibodies in blocking buffer solution. Fluorescently conjugated secondary antibodies were 
from Molecular Probes (Thermo-Fisher Scientific; Alexa Fluor488 #A11029). Samples were 
mounted in ProLong Gold antifade reagent with DAPI (#P36935, Thermo-Fisher Scientific) 
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on 1.5 mm-thick coverslips. Image acquisitions were performed using a confocal microscope 
(SP8, Leica Microsystems GmbH, Wetzlar, Germany) at 63x (1.4 NA) magnification. Z-
stacks were acquired every 300 nm; 10 fields/sample. Offline analysis was performed using 
the ImageJ software and the JACoP plugin for co-localization studies. For each set of 
experiments, all images were acquired using identical exposure settings. For cholesterol 
investigation, Filipin (F-9765, Sigma-Aldrich) staining was carried out. Briefly, cells were 
fixed as described above and blocked with 1.5 mg/ml of glycine in PBS for 10 min at RT to 
quench the PFA. Cells were incubated for 2 h at RT with filipin (0.05 mg/ml in 10% FBS-
PBS solution). Confocal images were acquired at 63x (1.4 NA) magnification, using 405 nm 
excitation wavelength and filter-set 430-nm long pass filter. 
 
Lipidomic and Proteomic Studies 
Materials. Solvents and chemicals were purchased from Sigma-Aldrich (Milan, Italy). For 
proteomics, TMT sixplex kits and C18 spin columns were purchased from Thermo-Fisher 
Scientific (Waltham, MA, USA). LC-MS instruments and columns, Markerlynx and PLGS 
software were purchased from Waters Inc. (Milford, MS, USA). The Xcms software 
(https://xcmsonline.scripps.edu) was used for lipidome data analysis. The Mascot software 
was purchased from Matrix Science Ltd (London, UK). Lipid identification was carried out 
using the publicly available database METLIN (https://metlin.scripps.edu/) and LIPIDMAPS 
(http://www.lipidmaps.org/). Gene ontology and pathway analysis was performed using 
DAVID Bioinformatics Resources (v 6.8). We used DAVID default population (Rattus 
norvegicus) background in enrichment calculation.[62,63] Heat maps were generated using the 
MeV TM4 software V 4.9 (http://www.tm4.org). The UNIPROT database 
(http://www.uniprot.org/) was used to perform manual annotation of biological functions of 
proteins. 
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Sample preparation. For all the “omics” studies, primary astrocytes were plated in 60 mm 
Petri dishes pre-coated with 0.01 mg/ml PDL at a density of 1x106 cell/dish, then incubated 
for 72 h with either 10 µg/ml of FLG or GO and the respective control solutions (see above). 
Five biological replicates of primary astrocyte cultures from two independent preparations 
(individual rats) were prepared and used for both proteomics and lipidomics analysis. 
 
Untargeted Lipidomics 
Sample preparation. At the end of the incubation (72 h) cells were scraped, washed with PBS 
and immediately transferred into 1.5 ml Eppendorf tubes. Cell lipid content was then 
extracted using a Bligh-Dyer protocol.[64] In brief, 2 ml of 1:2 chloroform/methanol mixture 
(v/v) was added to the vials and vortexed for 30 s. Chloroform (0.5 ml) and water (0.5 ml) 
were then sequentially added and thoroughly mixed after each addition. The samples were 
then centrifuged for 15 min at 3,500 g at RT. At the end of the process, the organic (lower) 
phase (~1.5 ml) was transferred to glass vials. The aqueous phases were re-extracted to 
increase the overall recovery. The organic phases from both extractions were pooled in a glass 
vial and dried under a nitrogen stream. The extracted lipids were re-dissolved in 0.1 ml of a 
9:1 methanol: chloroform solution and analyzed by liquid chromatography coupled to high-
resolution mass spectrometry. 
Data acquisition. Untargeted lipidomics of astrocyte lipid extracts was performed on a UPLC 
Acquity system coupled to a Synapt G2 QToF high-resolution mass spectrometer. Lipids were 
separated on a CSH C18 column (1.7 micron particle size, 2.1 x 100 mm). Mobile phase A 
consisted of acetonitrile: water (60:40) with 10 mM ammonium formate and mobile phase B 
consisted of acetonitrile: isopropyl alcohol (10:90) with 10 mM ammonium formate. The 
following gradient program was applied: 15% B for 1 min after injection, then increase to 
60% B in 9 min, then to 75% B in 8 min and then to 100% B in further 2.5 min. An isocratic 
100% B step was then maintained for 2.5 min and the column was subsequently reconditioned 
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to 15% B for 2 min. Total run time was 25 min with the following conditions: flow rate, 0.4 
ml/min; column temperature, 55 °C; injection volume, 6 µl. The instrument was operated in 
positive ESI mode. MS source parameters were as follows: capillary and cone voltages were 
set at 2.8 kV and 30 V respectively. Source and desolvation temperature were set at 100 °C 
and 450 °C respectively. Desolvation gas and cone gas (N2) flows were 800 and 50 L/h, 
respectively. Mass spectra were recorded in MSe mode with MS/MS fragmentation 
performed in the trap region on the instrument. Low-energy scans were acquired at a fixed 4 
eV collision energy, and high-energy scans were acquired using a collision energy ramp from 
20 to 40 eV. Spectra were recorded at a mass resolution of 20,000 in the range of m/z 50 to 
m/z 1200. The scan rate was set to 0.3 spectra per second. A leucine-enkephalin solution (2 
ng/ml) was continuously infused in the ESI source (4 µl/min) and acquired every 30 s for real-
time mass axis recalibration. All the samples were run in random order. QC samples, 
consisting of a pool of all the samples from the four experimental groups, were acquired every 
five samples and were used to assess system suitability, performance, and reproducibility. 
Data analysis. Multivariate data analysis of LC-MS features was performed using the Waters 
Markerlynx 4.1 software with the EZinfo 2.0 (Umetrics, Umea, Sweden) software package. 
Principal Component Analysis (PCA)[65] was performed. The peak areas of the observed 
features were normalized by the total ion current and Pareto-scaled prior to PCA. Scores plots 
were used to visualize differences between challenging GNMs and their corresponding 
vehicles for each biological replicate. XCMSonline[66] was used for univariate lipidomic data 
analysis. All LC-MS raw data files were converted to the .netCDF format using the waters 
DataBridge software. The files were then uploaded to XCMSOnline and processed as a pair 
group experiment using the default UPLC-High Res POS parameters. Briefly, the centWave 
method was used for feature detection (m/z tolerance  =  15 ppm, min peak width  =  2 s, max 
peak width  =  25 s). The obiwarp method was used for retention time correction (profStep  =  
0.5) and chromatograms were aligned using the following parameters: mzwid 0.01, minfrac 
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0.5, bw  =  2. A data matrix reporting the observed accurate mass and retention times (tR) for 
all the features was generated and converted into an excel file. Univariate statistical analysis 
was then performed using a two-tailed unpaired Student’s t-test between GNMs and the 
corresponding vehicle groups using Microsoft Excel. Following this procedure, only the 
features present in both rats were retained. Only the most significant features, showing 
p < 0.05 and an absolute fold change of at least 20% in the comparison were used for further 
annotation. 
Lipid identification. Lipid identification was performed by interrogating the web-based 
algorithms METLIN[67] and LIPIDMAPS[68] using the accurate mass measured for each 
feature. The following adduct species were searched: [M+H]+, [M+NH4]+, [M+H-H2O]+, 
[M+Na]+, and [M+K]+. A maximum of 5 ppm tolerance in mass accuracy was allowed. 
Putative IDs were finally verified using class-specific retention time and tandem mass 
analysis.[69] 
 
Untargeted Proteomics 
Sample preparation. At the end of the 72 h incubation, cells from the four groups (incubated 
with GO, FLG, and respective controls) were scraped and washed with PBS to remove serum, 
then lysed by MilliQ water addition. Following the BCA protein assay, 50 µg of proteins were 
collected from all the samples and transferred to Eppendorf tubes. Samples were then 
isotopically labeled using the TMT sixplex kit,[30] following the protocol suggested by the 
vendor. In short: samples were reduced with dithiothreitol, alkylated with iodoacetic acid and 
then digested overnight with trypsin (1:50 in weight with the protein). At the end of the 
digestion, peptides were labeled separately using TMT sixplex tags then pooled together. The 
following labeling strategy was used: reporters 126,127,128 for technical replicates of the 
challenging GNMs, reporters 129,130,131 for the technical replicates of the corresponding 
vehicle. Peptides resulting from the overnight digestion were fractionated offline at high pH 
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on a reversed phase C18 spin column (0.1% trimethylamine) using increasing concentrations 
of acetonitrile. A total of 8 fractions were collected for each experiment. The content from 
each fraction was dried under vacuum then re-dissolved in 80 µl of 3% ACN with 0.1% 
formic acid for LC-MS/MS analysis. 
LC-MS/MS analysis. The tryptic peptide mixture was analyzed using a Synapt G2 QToF 
instrument equipped with a nanoACQUITY liquid chromatographer and a nanoSpray ion 
source. Peptides were separated on a BEH nanobore column (75 micron ID x 25 cm length) 
using a linear gradient of ACN in water from 3 to 55% in 2 h, followed by a washout step at 
90% ACN (10 min) and a reconditioning step to 3% for 20 min. Flow rate was set to 300 
nl/min. Spray voltage was set to 1.6 kV, cone voltage was set to 28 V, spray gas was set to 0.3 
l/min. Survey spectra were acquired over the 50-1600 m/z scan range. Multiply (2+, 3+ and 
4+) charged ions between 300 and 1400 m/z were selected as precursors for DDA tandem 
mass analysis and fragmented in the Trap region of the instrument. Collision energy values 
were automatically selected by the software using dedicated charge-state dependent CE/m/z 
profiles. Every 60 s a single leucine-enkephalin (2 ng/ml) MS scan was acquired by the 
LockMass ion source for spectra recalibration. 
Data analysis. The acquired raw data files were processed using the PLGS software to 
recalibrate the mass spectra and generate the precursor-fragments peaklist. Protein 
identification and quantification was performed by interrogating the SwissProt database using 
the MASCOT Server software.[70] The search parameters were set as follows: quantification: 
TMT6plex; fixed modifications: carbamidomethyl (C), TMT6plex (N-term), TMT6plex (K); 
variable modifications: acetyl (K), acetyl (N-term), deamidated (NQ), methyl (DE), oxidation 
(M), phospho (ST), phospho (Y); peptide tolerance: 30 ppm; fragment tolerance: 0.5 Da; 
maximum allowed missed cleavages: 2. At least 2 peptides were required for a positive 
protein identification and quantification. A significance threshold of p>0.05 was set for 
protein identification in the MASCOT search. Proteins sharing the same set or subset of 
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peptides were considered as a single entry (MASCOT Protein Families). Protein expression 
ratio was normalized by the average ratio of all the peptides assigned to proteins. 
 
Protein Extraction and Western Blotting Analysis 
Total protein lysates were obtained from cells lysed in RIPA buffer (10 mM Tris-HCl, 1 mM 
EDTA, 0.5 mM EGTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% sodium dodecyl 
sulfate, 140 mM NaCl) containing protease and phosphatase inhibitor cocktails (Roche, 
Monza, Italy). The soluble fraction was collected and protein concentration was determined 
using the BCA Protein Assay Kit (Thermo-Fischer Scientific). For western blotting, protein 
lysates were denatured at 99 °C in 5X sample buffer (62.5 mM Tris-HCL, pH 6.8, 2% SDS, 
25% glycerol, 0.05% bromophenol blue, 5% b-mercaptoethanol, deionized water) and 
separated on SDS-polyacrylamide gels (SDS-PAGE). The following antibodies were used: 
mouse monoclonal anti-GFAP (#G3893, Sigma-Aldrich) and rabbit monoclonal anti-GAPDH 
(#2118, Cell Signaling Technology; MA, USA). Signal intensities were quantified using the 
ChemiDoc MP Imaging System (Biorad, Hercules, CA, USA). 
 
RNA Preparation and Real-Time PCR Analysis 
Total RNA was extracted with Trizol (Invitrogen, Carlsbad, CA, USA) according to the 
manufacturer’s instructions, purified using RNeasy MinElute Cleanup Kit (Qiagen, Hilden, 
Germany), and reverse transcribed into cDNA using the SuperScript IV First-Strand Synthesis 
System (Invitrogen). Gene expression was measured by quantitative real time PCR using the 
CFX96 Touch Real-Time PCR Detection System (Biorad). Relative gene expression was 
determined using the 2-DDCT method. Gusb and Hprt1 were used as reference genes. The list 
of primers used is provided in Table S1. 
 
Calcium Imaging 
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Cultures were loaded for 30 min at 37 °C with 1 µg/ml cell-permeable Fura-2 AM (#F1221, 
ThermoFisher) in the culture medium. Cells were then washed in recording buffer (140 NaCl, 
4 KCl, 2 MgCl2, 2 CaCl2, 10 HEPES, 5 glucose, pH 7.4, with NaOH) for 30 min at 37 °C to 
allow hydrolysis of the esterified groups. Coverslips with cells were mounted on the imaging 
chamber and loaded with 0.5 ml of recording buffer. Fura-2-loaded cultures were observed 
with an inverted epifluorescence microscope Leica DMI6000 (Leica Microsystems GmbH, 
Wetzlar, Germany) using a 63x (1.4 NA) oil-immersion objective, and recordings were 
performed from visual fields containing 5 ± 2 astrocytes on average. During the analysis, we 
selected the cells by drawing regions of interest (ROI) around their bodies to reduce any 
background. Samples were excited at 340 nm and 380 nm by a mercury metal halide lamp 
(LEICA EL6000, Leica Microsystems). Excitation light was separated from the emitted light 
using a 395 nm dichroic mirror. Images of fluorescence emission > 510 nm were acquired 
continuously for a maximum of 2400 s (200 ms individual exposure time) by using an Orca-
ER IEEE1394 CCD camera (Hamamatsu Photonics, Hamamatsu City, Japan). The imaging 
system was controlled by the integrated imaging software package (Leica LAS AF software, 
Leica Application Suite Advance Fluorescence, version 3.3, Leica Microsystems). In order to 
monitor spontaneous Ca2+ oscillations, astrocytes were recorded for 15 min under baseline 
conditions. To evoke Ca2+ transients, astrocytes were stimulated, after 1 min of baseline 
acquisition, with 10 µM of ATP (#A2383, Sigma-Aldrich, Milan, Italy). For thapsigargin 
(#1138, Tocris, Avonmouth, Bristol, UK) experiments, cells were first perfused with a 
standard Ca2+-free extracellular solution (Ca2+ was replaced with 5 mM EGTA); after 30 s of 
baseline acquisition, thapsigargin (1 µM) was added. After [Ca2+]i returned to baseline levels, 
CaCl2 (2 mM) was added back to the extracellular medium to induce Ca2+ entry. For 
cholesterol depletion experiments, astrocytes were pretreated with methyl-beta-cyclodextrin 
(MβCD, 7.5 mM; C4555 Sigma-Aldrich) for 30 min before proceeding with Fura2-AM 
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incubation. Fluorescence intensity ratios (R) were calculated for the time course of the 
experiment according to the equation below: 
 
 
 
where MV (mean value) is the average pixel intensity for each ROI, and λx-λe is the excitation 
(collection) wavelength. For quantitative analysis, the percentage increase in fluorescence 
(ΔF) was calculated by subtracting the baseline fluorescence (F0) from the total fluorescence 
(F) and normalizing the difference by the F0 values (ΔF/F0). 
 
Statistical Analysis 
Data are expressed as means ± sem throughout. Normal distribution was assessed using 
D’Agostino-Pearson’s normality test. In case of two experimental groups, data were analyzed 
using the Student’s t-test or the Mann-Whitney's U-test. When more than 2 experimental 
groups with normally distributed data were involved, one-way or two-ways ANOVA was 
used, followed by the Bonferroni's multiple comparison test.  Significance level was preset to 
p<0.05. Statistical analysis was carried out using the Prism6 software (GraphPad Software, 
Inc.).  
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Figure S1. mRNA levels of Ca2+ and integrin binding family member 2 (Cib2), calreticulin 
(Calr), calpastatin (Cast) and calcineurin binding protein 1 (Cabin1) were quantified by qRT-
PCR in primary astrocytes treated with FLG or GO at 10 µg/ml for 72 h. Gusb and Hprt1 
were used as reference genes. *p<0.05, **p<0.01; one-way ANOVA/Bonferroni’s tests; n=6. 
Data are expressed as mean ± sem 
 
 
Table S1. List of primers used for qRT-PCR. 
Gene Symbol Forward sequence  Reverse sequence 
Cib2   AGATGAGGTAGTGCTTGT TCAGATTCGGATGTGGAA 
Calr GGTGTTTGTCTTTAATTCTTCA TTCCTCCATACCTGTTCC 
Cast CCTTAGATTTCAAATGCTACC TCTCTTGTCAGTGCCTTA 
Cabin1 GAGGAGGAAGATGATCCA TCTCAGATTCCATGAATGTG 
 
